Category archives for: Online Pharmacies

Mice losing their allure as experimental subjects to study human disease

Recent research has revealed that clinical trials involving the rodents do not automatically produce effective treatments for humans On 19 November 2014 the journal Nature published the conclusions of a study carried out by the Encode international consortium, comparing the systems controlling gene activity in mice and in humans. The four articles on this topic […]

NABP, Stakeholders Release Consensus Document on the Challenges and ‘Red Flag’ Warning Signs Related to Prescribing and Dispensing Controlled Substances

A coalition of stakeholder organizations released a consensus document representing the medical, pharmacist, and supply chain spectrum highlighting the challenges and ‘red flag’ warning signs related to prescribing and dispensing controlled substance (CS) prescriptions. NABP Newsroom

Consumer watchdog to appeal federal court decision on Pfizer

Australian Competition and Consumer Commission alleged pharmaceutical giant misused market power with discounts on its generic version of its drug Lipitor Australia’s consumer watchdog will appeal against a federal court decision that found the pharmaceutical giant Pfizer had not engaged in anti-competitive conduct. The Australian Competition and Consumer Commission alleged Pfizer contravened the Competition and […]

AstraZeneca chief rewarded with 5% pay rise after repelling Pfizer takeover bid

Pascal Soriot, chief executive of the Anglo-Swedish pharmaceutical company, earned £3.4m last year despite pre-tax profits falling 62% to $ 1.2bn Pascal Soriot, the chief executive of the drugmaker AstraZeneca, saw his pay rise by 5% to £3.5m in 2014 after he helped resist a takeover approach from its US rival Pfizer. The Anglo-Swedish company […]

NABP, Stakeholders Release Consensus Document on the Challenges and “Red Flag” Warning Signs Related to Prescribing and Dispensing Controlled Substances

A coalition of stakeholder organizations released a consensus document representing the medical, pharmacist, and supply chain spectrum highlighting the challenges and “red flag” warning signs related to prescribing and dispensing controlled substance prescriptions.  NABP Newsroom

Endometriosis: periods aren’t meant to be this painful, but there is hope – video

One in 10 women suffer from endometriosis, a condition in which the lining of the womb (endometrium) grows outside the womb, attaching to other organs, causing excruciating pain and reducing fertility. Many women suffering from the chronic disease don’t even know they have it: “Periods are painful, get over it,” they are told. When Sylvia […]

AbbVie takes over Pharmacyclics in latest Big Pharma takeover

The $ 21bn takeover adds major blood cancer treatments to pharmaceutical company’s portfolio US drugmaker AbbVie is beefing up its cancer portfolio with the $ 21bn takeover of California-based Pharmacyclics. The deal comes six months after a US crackdown on tax inversion deals scuppered AbbVie’s $ 54bn acquisition of London-listed Shire. The move will reduce […]

Nurofen manufacturer sued over false claims on packets

Tablets for back pain, period pain, migraine pain and tension headaches marketed differently despite being exactly the same product Australia’s competition watchdog is taking the maker of the painkiller Nurofen to court over false claims about its “specific pain” product range. Nurofen Back Pain, Nurofen Period Pain, Nurofen Migraine Pain and Nurofen Tension Headache are […]

The IoD is right to call for more clarity on fund manager pay

How can anyone lecture against excessive pay when they refuse to disclose how much they are paid themselves? Not all fund managers are deaf on the subject of soaring boardroom pay at public companies. The money-management industry has been obliged to appear vaguely concerned by a combination of self-interest, chivvying by government and general disquiet […]

Cat allergy treatment could net billions for Circassia

Oxford-based pharma in final test stage for cat allergy injection which could net firm more than £1bn a year A British company which counts star fund manager Neil Woodford among its backers, is planning to put a new injection on the market for people allergic to cats. Circassia, which in March pulled off London’s biggest […]

© 2017 Drugs News All rights reserved.       Privacy Policy       Contact Us